Advanced NMR reported a $1.7 million net loss for its 1995 fiscalyear (end-September), primarily due to losses incurred by itsAdvanced Mammography Systems subsidiary. AMS is awaiting regulatoryclearance to begin marketing a dedicated MR mammography
Advanced NMR reported a $1.7 million net loss for its 1995 fiscalyear (end-September), primarily due to losses incurred by itsAdvanced Mammography Systems subsidiary. AMS is awaiting regulatoryclearance to begin marketing a dedicated MR mammography scanner(SCAN 3/15/95).
Advanced NMR, of Wilmington, MA, said the loss came on revenuesof $8.6 million. ANMR's 1995 fiscal year only included revenuesfor nine months because it changed its fiscal year-end to Sept.30 from Dec. 31 when it merged with imaging services firm MedicalDiagnostics (MDI).
ANMR said the company would have been marginally profitablein fiscal 1995 were it not for losses incurred by Advanced MammographySystems. In addition, ANMR's results included only one month ofrevenue from MDI. ANMR believes MDI will contribute $25 millionin revenue in fiscal 1996.
For the comparable nine months of 1994, ANMR posted revenuesof $5.2 million and a net loss of $1.3 million.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Meta-Analysis Shows Merits of AI with CTA Detection of Coronary Artery Stenosis and Calcified Plaque
April 16th 2025Artificial intelligence demonstrated higher AUC, sensitivity, and specificity than radiologists for detecting coronary artery stenosis > 50 percent on computed tomography angiography (CTA), according to a new 17-study meta-analysis.